The GESEA Expert Level 3 Oncology Diploma represents the highest level of surgical accreditation within the GESEA Educational Programme. The certification was developed as a collaboration between ESGO and ESGE.
The programme combines structured training, clinical exposure and rigorous skills-based assessment. The diploma certifies expert proficiency in complex oncological laparoscopic procedures and adherence to the highest European standards of surgical quality and patient safety.
Programme structure
The GESEA Expert Level 3 Oncology Diploma consists of three core components:
- eLearning modules in advanced oncological procedures
- Clinical attachment (minimum four weeks) in an ESGO-accredited centre in Europe
- Objective surgical skills assessment based on submitted procedural videos
Who is it for?
The programme is designed for experienced gynaecological oncologists with advanced laparoscopic skills who wish to obtain formal European-level recognition of their expert surgical competence.
Application
The programme is currently open for registration.
To apply, please visit the GESEA platform.
Certification
Successful candidates will receive the GESEA Expert Level 3 Oncology Diploma, jointly endorsed by ESGE and ESGO.
-
1. Application
GESEA MIGS Diploma/ESGO Fellowship Diploma
-
2. e-Learning module completion
-
3. Clinical observership
Minimum 4 weeks at an ESGO-accredited centre
-
4. Assessment of surgical videos
(Peer-reviewed by expert surgeons)
- Paraaortic lymphadenectomy (MIS)
- Sentinel lymph node mapping
- Infra-colicomentectomy
- Lateral pelvic spaces approach (MIS)
-
5. GESEA Expert Level 3 Oncology Diploma
Upcoming events
ESGO 2027 Congress
Vaginal and Urinary Reconstruction
Carlos MartÃnez Gómez, Sergi Fernández, Elena Rodriguez González, Félix Boria, Manel Montesinos, Giulio Ricotta, Gabrielle van Ramshorst
Special issue: Gynecologic Oncology Practice in Low & Middle Resource Settings
Anisa Mburu, Ricardo Dos Reis, Vanessa Alvarenga
ASYGO-ENYGO 2nd Joint Webinar: From Challenges to Solutions: Building Sustainable Careers for Young Gynecologic Oncologist
Miseon Kim Nakazawa, Houssein El Hajj, Jun-Hyeong Seo, Sara Nasser, Ga Won Yim, Aleksandra Strojna
Vision and Innovation: A Tribute to Prof. Pedro T. RamÃrez
GOC-ESGO 2nd Joint Webinar: Mirvetuximab Soravtansine (MIRV) and the Growing Real-World Evidence Emerging from European Practice
Maria Kfoury, Sabrina Cecere, Yvette Drew, Aalok Kumar, Annamaria Ferrero
Surgical Site Complications in Gynecologic Oncology
Malak Moubarak